Moreover, in 2017, in a study performed by Zhang and co-workers it was shown that in patients suffering from gastric cancer, the increase in Lgr5 markers caused by the disturbance in miR-132 expression resulted in more resistant to cisplatin during the treatment process (20). Here, LGR5 is linked to gastric cancer.